Marshall H. Woodworth - Mar 1, 2024 Form 4 Insider Report for NeuroBo Pharmaceuticals, Inc. (NRBO)

Role: Chief Financial Officer
Signature: /s/ Phillip D. Torrence, by Power of Attorney
Stock symbol: NRBO
Transactions as of: Mar 1, 2024
Transactions value $: $0
Form type: 4
Date filed: 3/4/2024, 09:20 PM
Previous filing: Oct 30, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NRBO	Common Stock	Award	$0	+33.5K		$0.00	33.5K	Mar 1, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units ("RSUs") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan, which vest as follows: (i) 30% of the RSUs vest on the first anniversary of the grant date; (ii) 30% of the RSUs vest on the second anniversary of the grant date; and (iii) the remainder of the RSUs vest in equal monthly installments on the last day of each full month over the 12 months following the second anniversary of the grant date.

Content

Represents a grant of restricted stock units ("RSUs") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan, which vest as follows: (i) 30% of the RSUs vest on the first anniversary of the grant date; (ii) 30% of the RSUs vest on the second anniversary of the grant date; and (iii) the remainder of the RSUs vest in equal monthly installments on the last day of each full month over the 12 months following the second anniversary of the grant date.